serw-MX  [xml]  
 


    
 DeCS Categories

D01 Inorganic Chemicals .
D01.045 Alkalies .
D01.045.125 Carbonates .
D01.045.125.500 Lithium Carbonate .
D01.200 Carbon Compounds, Inorganic .
D01.200.275 Carbonic Acid .
D01.200.275.150 Carbonates .
D01.200.275.150.550 Lithium Carbonate .
D01.510 Lithium Compounds .
D01.510.475 Lithium Carbonate .
D02 Organic Chemicals .
D02.033 Alcohols .
D02.033.800 Sugar Alcohols .
D02.033.800.609 Mannitol .
D02.033.800.609.500 Mitobronitol .
D02.241 Carboxylic Acids .
D02.241.081 Acids, Acyclic .
D02.241.081.114 Butyrates .
D02.241.081.114.968 Isobutyrates .
D02.241.081.114.968.500 Fibric Acids .
D02.241.081.114.968.500.500 Clofibric Acid .
D02.355 Ethers .
D02.355.726 Phenyl Ethers .
D02.355.726.305 Fibric Acids .
D02.355.726.305.500 Clofibric Acid .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.392 Hydrocarbons, Alicyclic .
D02.455.426.392.368 Cycloparaffins .
D02.455.426.392.368.450 Cyclopentanes .
D02.455.426.392.368.450.350 Cycloleucine .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.657 Phenols .
D02.455.426.559.389.657.654 Phenyl Ethers .
D02.455.426.559.389.657.654.305 Fibric Acids .
D02.455.426.559.389.657.654.305.500 Clofibric Acid .
D02.455.526 Hydrocarbons, Halogenated .
D02.455.526.728 Mustard Compounds .
D02.455.526.728.650 Nitrogen Mustard Compounds .
D02.455.526.728.650.529 Mechlorethamine .
D09 Carbohydrates .
D09.853 Sugar Alcohols .
D09.853.609 Mannitol .
D09.853.609.500 Mitobronitol .
D12 Amino Acids, Peptides, and Proteins .
D12.125 Amino Acids .
D12.125.072 Amino Acids, Cyclic .
D12.125.072.170 Cycloleucine .
F03 Mental Disorders .
F03.625 Neurodevelopmental Disorders .
F03.625.094 Attention Deficit and Disruptive Behavior Disorders .
F03.625.094.150 Attention Deficit Disorder with Hyperactivity .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Mechlorethamine .
Bis(2-chloroethyl)methylamine .
Caryolysine .
Cloramin .
Embichin .
Mechlorethamine Hydrochloride .
Mechlorethamine Hydrochloride N-Oxide .
Mechlorethamine N-Oxide .
Methylchlorethamine .
Mitomen .
Mustargen .
NSC-10107 .
NSC-762 .
Nitrogranulogen .
Nitromin .
Hydrochloride N-Oxide, Mechlorethamine .
Hydrochloride, Mechlorethamine .
Mechlorethamine Hydrochloride N Oxide .
Mechlorethamine N Oxide .
N-Oxide, Mechlorethamine Hydrochloride .
N-Oxide, Nitrogen Mustard .
NSC 10107 .
NSC 762 .
NSC10107 .
NSC762 .
Nitrogen Mustard N Oxide .
Chlorethazine .
Chlormethine .
Mechlorethamine Oxide .
Mustine .
Nitrogen Mustard .
Nitrogen Mustard N-Oxide .
A biologic alkylating agent that exerts its cytotoxic effects by forming DNA ADDUCTS and DNA interstrand crosslinks, thereby inhibiting rapidly proliferating cells. The hydrochloride is an antineoplastic agent used to treat HODGKIN DISEASE and LYMPHOMA. .
1.00
123102
 
Clofibric Acid .
2-(4-Chlorophenoxy)-2-methylpropionic Acid .
NSC-1149 .
p-Chlorophenoxyisobutyrate .
p-Chlorophenoxyisobutyric Acid .
NSC 1149 .
NSC1149 .
Clofibrinic Acid .
An antilipemic agent that is the biologically active metabolite of CLOFIBRATE. .
0.44
111362
 
Cycloleucine .
Aminocyclopentanecarboxylic Acid .
NSC 1026 .
1 Aminocyclopentanecarboxylic Acid .
Acid, 1-Aminocyclopentanecarboxylic .
Acid, Aminocyclopentanecarboxylic .
1-Aminocyclopentanecarboxylic Acid .
An amino acid formed by cyclization of leucine. It has cytostatic, immunosuppressive and antineoplastic activities. .
0.43
21185
 
Attention Deficit Disorder with Hyperactivity .
ADDH 1012 .
Attention Deficit Disorders with Hyperactivity .
Attention Deficit Hyperactivity Disorders .
Attention Deficit-Hyperactivity Disorder .
Attention Deficit Disorders .
Attention Deficit-Hyperactivity Disorders .
Deficit Disorder, Attention .
Deficit Disorders, Attention .
Deficit-Hyperactivity Disorder, Attention .
Deficit-Hyperactivity Disorders, Attention .
Disorder, Attention Deficit .
Disorder, Attention Deficit-Hyperactivity .
Disorders, Attention Deficit .
Disorders, Attention Deficit-Hyperactivity .
Dysfunction, Minimal Brain .
Syndromes, Hyperkinetic .
Brain Dysfunction, Minimal .
Hyperkinetic Syndrome .
Minimal Brain Dysfunction .
Attention Deficit Hyperactivity Disorder .
Attention Deficit Disorder .
A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V) .
0.42
77424412
 
Mitobronitol .
Myelobromol .
NSC-94,100 .
NSC-94100 .
NSC 94,100 .
NSC 94100 .
NSC94,100 .
NSC94100 .
Dibromomannitol .
Brominated analog of MANNITOL which is an antineoplastic agent appearing to act as an alkylating agent. .
0.42
050
 
Lithium Carbonate .
CP-15,467-61 .
Dilithium Carbonate .
Eskalith .
Lithane .
Lithium Bicarbonate .
Lithobid .
Lithonate .
Lithotabs .
Micalith .
NSC-16895 .
Priadel .
Quilinorm-retard .
Bicarbonate, Lithium .
CP 15,467 61 .
CP15,46761 .
Carbonate, Dilithium .
Carbonate, Lithium .
NSC 16895 .
NSC16895 .
Quilinorm retard .
Quilinormretard .
A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems. .
0.40
472808